{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:20:23Z","timestamp":1781713223956,"version":"3.54.5"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Medical Health Technology Project of Zhejiang","award":["2021KY749"],"award-info":[{"award-number":["2021KY749"]}]},{"name":"Medical Health Technology Project of Zhejiang","award":["2023KY804"],"award-info":[{"award-number":["2023KY804"]}]},{"name":"Medical Health Technology Project of Zhejiang","award":["2024ZL101"],"award-info":[{"award-number":["2024ZL101"]}]},{"name":"Medical Health Technology Project of Zhejiang","award":["LQ21H030010"],"award-info":[{"award-number":["LQ21H030010"]}]},{"name":"Medical Health Technology Project of Zhejiang","award":["LY24H030002"],"award-info":[{"award-number":["LY24H030002"]}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>\u2003<\/jats:title>\n                  <jats:p>Context: Research regarding the treatment of inflammatory bowel disease (IBD) with probiotics has not yielded consistent results.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The aim of this meta-analysis was to evaluate the efficacy of probiotics supplementation in patients with IBD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Data Sources<\/jats:title>\n                  <jats:p>Randomized controlled trials (RCTs) evaluating the efficacy of probiotics in patients with IBD were searched in PubMed, the Google Scholar database, Web of Science, and CrossRef for the period July 2003 to June 2023.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Data Extraction<\/jats:title>\n                  <jats:p>The RCTs were extracted, independently by 2 authors, according to the PICOS criteria.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Data Analysis<\/jats:title>\n                  <jats:p>Seven studies, including a total of 795 patients, met the study criteria. Five end points were selected to evaluate the efficacy. Of these, 3 indicators showed a statistically significant difference in efficacy: C-reactive protein (odds ratio [OR]: \u20132.45, 95% confidence interval [CI]: \u20133.16, \u20131.73, P\u2009&amp;lt;\u2009.01), the number of fecal Bifidobacterium (OR: 3.37, 95% CI: 3.28, 3.47, P\u2009&amp;lt;\u2009.01), and Lactobacillus(OR: 2.00, 95% CI: 1.91, 2.09, P\u2009&amp;lt;\u2009.01). The other 2 indicators (disease activity for Crohn\u2019s disease and for ulcerative colitis) showed no statistically significant difference, while the OR reflected a positive correlation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Probiotics supplementation may have a positive effect on IBD by reducing clinical symptoms, reducing the serological inflammatory markers, and increasing favorable gut flora in patients with IBD. Additional RCTs are needed to evaluate the therapeutic effect of probiotics in IBD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/nutrit\/nuae022","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T03:07:14Z","timestamp":1711768034000},"page":"e65-e73","source":"Crossref","is-referenced-by-count":12,"title":["Efficacy of probiotic supplementation and impact on fecal microbiota in patients with inflammatory bowel disease: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1093","volume":"83","author":[{"given":"Mengque","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University , Hangzhou,","place":["China"]},{"name":"Institute of Gastroenterology, Zhejiang University , Hangzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3926-7783","authenticated-orcid":false,"given":"Wenluo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University , Hangzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University , Hangzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University , Hangzhou,","place":["China"]},{"name":"Institute of Gastroenterology, Zhejiang University , Hangzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University , Hangzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University , Hangzhou,","place":["China"]},{"name":"Institute of Gastroenterology, Zhejiang University , Hangzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binrui","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University , Hangzhou,","place":["China"]},{"name":"Institute of Gastroenterology, Zhejiang University , Hangzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyi","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University , Hangzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Los Angles General Medical Center , Los Angeles, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University , Hangzhou,","place":["China"]},{"name":"Institute of Gastroenterology, Zhejiang University , Hangzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,29]]},"reference":[{"key":"2025011020372111400_nuae022-B1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"2025011020372111400_nuae022-B2","doi-asserted-by":"publisher","first-page":"n1554","DOI":"10.1136\/bmj.n1554","article-title":"Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study","volume":"374","author":"Narula","year":"2021","journal-title":"BMJ."},{"key":"2025011020372111400_nuae022-B3","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/S2468-1253(22)00021-8","article-title":"Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus","volume":"7","author":"Ananthakrishnan","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025011020372111400_nuae022-B4","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1097\/CM9.0000000000000718","article-title":"Advances in the understanding of the intestinal micro-environment and inflammatory bowel disease","volume":"133","author":"Yan","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"2025011020372111400_nuae022-B5","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.gastrohep.2021.08.008","article-title":"Inflammatory bowel disease: the role of commensal microbiome in immune regulation","volume":"45","author":"Wah-Su\u00e1rez","year":"2022","journal-title":"Gastroenterol Hepatol"},{"key":"2025011020372111400_nuae022-B6","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025011020372111400_nuae022-B7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10787-019-00595-4","article-title":"A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn\u2019s disease","volume":"27","author":"Bjarnason","year":"2019","journal-title":"Inflammopharmacology"},{"key":"2025011020372111400_nuae022-B8","doi-asserted-by":"publisher","first-page":"242","DOI":"10.5152\/tjg.2018.18227","article-title":"Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: a randomized controlled trial","volume":"30","author":"Y\u0131lmaz","year":"2019","journal-title":"Turk J Gastroenterol"},{"key":"2025011020372111400_nuae022-B9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2174\/1871530319666181221150352","article-title":"Probiotics efficacy on oxidative stress values in inflammatory bowel disease: a randomized double-blinded placebo-controlled pilot study","volume":"19","author":"Ballini","year":"2019","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"2025011020372111400_nuae022-B10","doi-asserted-by":"publisher","first-page":"680","DOI":"10.5152\/tjg.2019.18426","article-title":"Effects of pentasa-combined probiotics on the microflora structure and prognosis of patients with inflammatory bowel disease","volume":"30","author":"Fan","year":"2019","journal-title":"Turk J Gastroenterol"},{"key":"2025011020372111400_nuae022-B11","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1007\/s10620-018-4946-2","article-title":"Efficacy of Bifidobacterium breve fermented milk in maintaining remission of ulcerative colitis","volume":"63","author":"Matsuoka","year":"2018","journal-title":"Dig Dis Sci"},{"key":"2025011020372111400_nuae022-B12","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.cgh.2013.02.021","article-title":"Saccharomyces boulardii does not prevent relapse of Crohn\u2019s disease","volume":"11","author":"Bourreille","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025011020372111400_nuae022-B13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.4166\/kjg.2015.65.4.215","article-title":"Effects of probiotics on gut microbiota in patients with inflammatory bowel disease: a double-blind, placebo-controlled clinical trial","volume":"65","author":"Shadnoush","year":"2015","journal-title":"Korean J Gastroenterol"},{"key":"2025011020372111400_nuae022-B14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2180-9-35","article-title":"Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors","volume":"9","author":"Jones","year":"2009","journal-title":"BMC Microbiol"},{"key":"2025011020372111400_nuae022-B15","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1172\/JCI44031","article-title":"Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism","volume":"121","author":"Yan","year":"2011","journal-title":"J Clin Invest"},{"key":"2025011020372111400_nuae022-B16","doi-asserted-by":"publisher","first-page":"G1060","DOI":"10.1152\/ajpgi.00202.2007","article-title":"Probiotics ameliorate the hydrogen peroxide\u2013induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism","volume":"294","author":"Seth","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2025011020372111400_nuae022-B17","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1053\/j.gastro.2006.11.022","article-title":"Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth","volume":"132","author":"Yan","year":"2007","journal-title":"Gastroenterology"},{"key":"2025011020372111400_nuae022-B18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000496426","article-title":"Beneficial effects of probiotic consumption on the immune system","volume":"74","author":"Maldonado Galdeano","year":"2019","journal-title":"Ann Nutr Metab"},{"key":"2025011020372111400_nuae022-B19","doi-asserted-by":"publisher","first-page":"18507","DOI":"10.1038\/srep18507","article-title":"Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses","volume":"6","author":"Rossi","year":"2016","journal-title":"Sci Rep"},{"key":"2025011020372111400_nuae022-B20","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature12331","article-title":"Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota","volume":"500","author":"Atarashi","year":"2013","journal-title":"Nature"},{"key":"2025011020372111400_nuae022-B21","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/ibd.21222","article-title":"Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis","volume":"16","author":"Ng","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"2025011020372111400_nuae022-B22","doi-asserted-by":"publisher","first-page":"16731","DOI":"10.1073\/pnas.0804812105","article-title":"Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients","volume":"105","author":"Sokol","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025011020372111400_nuae022-B23","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/ibd.20448","article-title":"Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun","volume":"14","author":"Lin","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"2025011020372111400_nuae022-B24","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1440-1746.2004.03181.x","article-title":"Lactobacillus plantarum 299: beneficial in vitro immunomodulation in cells extracted from inflamed human colon","volume":"19","author":"Pathmakanthan","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"2025011020372111400_nuae022-B25","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1136\/gut.52.7.975","article-title":"Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance","volume":"52","author":"McCarthy","year":"2003","journal-title":"Gut"},{"key":"2025011020372111400_nuae022-B26","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1136\/gut.51.5.659","article-title":"Increased mucosal tumour necrosis factor alpha production in Crohn\u2019s disease can be downregulated ex vivo by probiotic bacteria","volume":"51","author":"Borruel","year":"2002","journal-title":"Gut"},{"key":"2025011020372111400_nuae022-B27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nm1521","article-title":"Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors","volume":"13","author":"Rousseaux","year":"2007","journal-title":"Nat Med"},{"key":"2025011020372111400_nuae022-B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1902717","article-title":"Bifidobacterium dentium\u2013derived y-glutamylcysteine suppresses ER-mediated goblet cell stress and reduces TNBS-driven colonic inflammation","volume":"13","author":"Engevik","year":"2021","journal-title":"Gut Microbes."},{"key":"2025011020372111400_nuae022-B29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.redox.2018.02.003","article-title":"Hydrogen peroxide production by lactobacilli promotes epithelial restitution during colitis","volume":"16","author":"Singh","year":"2018","journal-title":"Redox Biol"}],"container-title":["Nutrition Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/nutritionreviews\/article-pdf\/83\/2\/e65\/57122697\/nuae022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/nutritionreviews\/article-pdf\/83\/2\/e65\/57122697\/nuae022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T20:39:54Z","timestamp":1736541594000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nutritionreviews\/article\/83\/2\/e65\/7637740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,29]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,3,29]]},"published-print":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/nutrit\/nuae022","relation":{},"ISSN":["0029-6643","1753-4887"],"issn-type":[{"value":"0029-6643","type":"print"},{"value":"1753-4887","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,3,29]]}}}